|
KMID : 0043320180410010001
|
|
Archives of Pharmacal Research
2018 Volume.41 No. 1 p.1 ~ p.13
|
|
|
The combination of curcumin and 5-fluorouracil in cancer therapy
|
|
Wei Yumeng
Yang Panjing
Cao Shousong
|
|
|
Abstract
|
|
|
|
5-Fluorouracil (5-FU) alone or in combination with other therapeutic drugs has been widely used for clinical treatment of various cancers. However, 5-FU-based chemotherapy has limited anticancer efficacy in clinic due to multidrug resistance and dose-limiting cytotoxicity. Some molecules and genes in cancer cells, such as nuclear factor kappa B, insulin-like growth factor-1 receptor, epidermal growth factor receptor, cyclooxygenase-2, signal transducer and activator of transcription 3, phosphatase and tensin homolog deleted on chromosome ten and Bcl-2 etc. are related to the chemoresistance and sensitivity of cancer cells to 5-FU. The activation of these molecules and genes expressions in cancer cells will be increased or decreased with long-term exposure of 5-FU. Curcumin has been found to be able to negatively regulate these processes. In order to overcome the problems of 5-FU, curcumin has been used to combine with 5-FU in cancer therapy.
|
|
|
KEYWORD
|
|
|
Curcumin, 5-Fluorouracil (5-FU), Multidrug resistance (MDR), Cytotoxicity, Anticancer efficacy, Combination therapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|